Yamamoto Nobuo, Nitta Mitsuyo, Kamei Miwako, Hara Kazuo, Watanabe Fumiyuki, Akagawa Keiko, Kurata Naomi
Division of Community Healthcare and Pharmacy, Department of Healthcare and Regulatory Sciences, Showa University School of Pharmacy, Tokyo, Japan.
Division of Health Communication, School of Pharmacy, Nihon University, Chiba, Japan.
Integr Pharm Res Pract. 2016 Mar 29;5:27-32. doi: 10.2147/IPRP.S100336. eCollection 2016.
This study was conducted to evaluate whether a community pharmacist's assistance during the treatment of a patient with a chronic illness would help to discover and improve issues regarding the treatment.
We employed a prospective intervention study with a control group. The patients ranging in age from 60 to 74, were using one of the six selected community pharmacies in the Tokyo metropolitan area. They had been prescribed six or fewer kinds of medications, one of which was amlodipine. The medication dosages covered 1 month or longer. Patients who agreed to participate in the study were randomly assigned to the groups at each pharmacy. For the patients in the intervention group, the pharmacists provided telephone counseling between physician visits, in addition to the time they visited the pharmacies to collect their medications. For the patients in the control group, the pharmacists provided counseling only at their pharmacies.
The average days of medication administration were 49.2 days for the 58 patients in the intervention group, and 49.8 days for the 53 patients in the control group, with the average number of medications being 3.4 items per person for both groups. Through the telephone counseling, we were able to collect more information, eg, changes in physical condition and occurrences of side effects, from the intervention group than from the control group. The rate of incident detection in the information from the intervention group was five times that of the control group, making subsequent incident resolutions faster.
This study suggested that phone counseling between physician visits could enable the identification of more issues regarding patients' conditions.
本研究旨在评估社区药剂师在慢性病患者治疗过程中的协助是否有助于发现并改善治疗相关问题。
我们采用了一项设有对照组的前瞻性干预研究。年龄在60至74岁之间的患者，使用东京都市区六家选定社区药房中的一家。他们被开具六种或更少种类的药物，其中一种是氨氯地平。药物剂量涵盖1个月或更长时间。同意参与研究的患者在每家药房被随机分组。对于干预组患者，药剂师在患者就诊期间除了在他们到药房取药时提供电话咨询。对于对照组患者，药剂师仅在药房提供咨询。
干预组的58名患者平均用药天数为49.2天，对照组的53名患者平均用药天数为49.8天，两组人均用药数量均为3.4种。通过电话咨询，我们从干预组收集到比对照组更多的信息，例如身体状况变化和副作用发生情况。干预组信息中的事件检出率是对照组的五倍，使得后续事件解决更快。
本研究表明，就诊期间的电话咨询能够发现更多关于患者病情的问题。
